AIRLINK 79.41 Increased By ▲ 1.02 (1.3%)
BOP 5.33 Decreased By ▼ -0.01 (-0.19%)
CNERGY 4.38 Increased By ▲ 0.05 (1.15%)
DFML 33.19 Increased By ▲ 2.32 (7.52%)
DGKC 76.87 Decreased By ▼ -1.64 (-2.09%)
FCCL 20.53 Decreased By ▼ -0.05 (-0.24%)
FFBL 31.40 Decreased By ▼ -0.90 (-2.79%)
FFL 9.85 Decreased By ▼ -0.37 (-3.62%)
GGL 10.25 Decreased By ▼ -0.04 (-0.39%)
HBL 117.93 Decreased By ▼ -0.57 (-0.48%)
HUBC 134.10 Decreased By ▼ -1.00 (-0.74%)
HUMNL 7.00 Increased By ▲ 0.13 (1.89%)
KEL 4.67 Increased By ▲ 0.50 (11.99%)
KOSM 4.74 Increased By ▲ 0.01 (0.21%)
MLCF 37.44 Decreased By ▼ -1.23 (-3.18%)
OGDC 136.70 Increased By ▲ 1.85 (1.37%)
PAEL 23.15 Decreased By ▼ -0.25 (-1.07%)
PIAA 26.55 Decreased By ▼ -0.09 (-0.34%)
PIBTL 7.00 Decreased By ▼ -0.02 (-0.28%)
PPL 113.75 Increased By ▲ 0.30 (0.26%)
PRL 27.52 Decreased By ▼ -0.21 (-0.76%)
PTC 14.75 Increased By ▲ 0.15 (1.03%)
SEARL 57.20 Increased By ▲ 0.70 (1.24%)
SNGP 67.50 Increased By ▲ 1.20 (1.81%)
SSGC 11.09 Increased By ▲ 0.15 (1.37%)
TELE 9.23 Increased By ▲ 0.08 (0.87%)
TPLP 11.56 Decreased By ▼ -0.11 (-0.94%)
TRG 72.10 Increased By ▲ 0.67 (0.94%)
UNITY 24.82 Increased By ▲ 0.31 (1.26%)
WTL 1.40 Increased By ▲ 0.07 (5.26%)
BR100 7,526 Increased By 32.9 (0.44%)
BR30 24,650 Increased By 91.4 (0.37%)
KSE100 71,971 Decreased By -80.5 (-0.11%)
KSE30 23,749 Decreased By -58.8 (-0.25%)
Pakistan

Pakistan, WHO to work together to gauge prevalence of Covid-19: Mirza

  • Health Services Academy and the Aga Khan University will also be a part of the study
Published June 17, 2020

(Karachi) Special Assistant to Prime Minister on Health Dr Zafar Mirza announced that Pakistan, with support from the World Health Organisation (WHO), will carry out a "unity study" on gauging the prevalence of coronavirus in the country.

Addressing a press conference in Islamabad on Wednesday, he said: "Pakistan is only South Asian nation to be included." He added that the Health Services Academy and the Aga Khan University will also be a part of the study.

Mirza highlighted that by the end of July, the government will have the results of the study which will help in analyzing the Covid-19 prevalence in the country. "Right now, our strategy is living with the virus. When we get to know about its prevalence, then we will be able to plan how to live with it."

Speaking on the occasion, WHO representative Dr Palitha Mahipala said: "The primary objective is to find the prevalence of antibodies by age and sex groups. The WHO study is population-based, determines to provide seriological prevalence and epidemiological traits of Covid-19. It will help to plan and stop spread of the virus."

Comments

Comments are closed.